Methylprednisolone sodium succinate

Methylprednisolone Sodium Succinate is a synthetic glucocorticoid corticosteroid used mainly as an anti-inflammatory and immunosuppressant agent. It is administered by intravenous or intramuscular injection, often in emergency or severe cases requiring rapid onset of action, including severe allergic reactions, asthma exacerbations, multiple sclerosis flare-ups, certain dermatologic conditions, endocrine disorders, and some gastrointestinal diseases. It is grouped under the following drug class(es): Corticosteroids, Steroids and Systemic corticosteroids. Its therapeutic use is listed as antirheumatic agents, dermatologicals, multiple sclerosis agents and osteoarthritis agents. The directory classifies it as a commercial API with a semi-synthetic source/manufacturing origin. Other names for this substance include Asmacortone, Metypred and Prednilem. Its PubChem CID is 23680530.

CAS No 2375-03-3
Molecular Formula C26H33NaO8
Molecular Weight 496.50 g/mol
Synonyms sodium;4-[2-[(6S,8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-6,10,13-trimethyl-3-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-yl]-2-oxoethoxy]-4-oxobutanoate

Frequently Asked Questions